Follow this innovation
[ via 
] [?]
Innovation
Synthesis of Ageladine A
Macquarie University
posted on 09/19/2012
A one-step synthesis method that uses inexpensive reagents and does not require water/oxygen exclusion.
Suggested Uses
• Pharmaceutical / Health-care: cancer therapeutic
• Pharmaceutical / Health-care: nutraceutical market
• Pharmaceutical / Health-care: macular degeneration/retinopathy
Advantages
• One-step synthesis method of the marine natural product ageladine A and the use of this method to synthesise a range of analogues.
• The method does not rely on complex, air-sensitive techniques or expensive chemistry and can potentially be carried out on kilogram scales.
Innovation Details
Detailed Description
In 2005 Associate Professor Peter Karuso identified that the marine natural product ageladine A had never been synthesised. It was first isolated by Fusetani and Nakao et al. (University of Tokyo) in 2003 and shown to have important (antiangiogenic) biological activity that was related to MMP inhibition.
Ageladine A was synthesised at Macquarie in 2005 and was first published in 2006, as a three step synthesis and subsequently as a one-step synthesis. This method devised by Karuso and carried out by Shengule was patented in 2008. Subsequently approximately 20 analogues have been synthesised.
File Number: MQ2008003
IP Protection
License Online
This innovation currently is not available for online licensing. Please contact Warren Bailey at Macquarie University for more information.
request more info
ProfileFind more innovations
